Clinical Trial Update: The Effects of Lipoic Acid on Glycaemic Control in Type 2 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessing the effects of alpha-lipoic acid on glycemic control in type 2 diabetes has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Alpha Lipoic Acid (alpha-lipoic acid)

Snippet

Sponsor: University of Edinburgh | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: WITHDRAWN